Anxiety can accelerate the development of Alzheimer's disease in some patients with mild cognitive impairment, a new study reports.
Researchers report that blocking a key receptor in the brain could neutralize the biological consequences of Alzheimer's.
Amyloid beta can be reduced when sugars are prevented from binding to a key enzyme associated with Alzheimer's disease, researchers report.
A new study reports a molecular chaperone can inhibit a key stage in the development of Alzheimer's disease.
According to a new study, triggering TREM2 could help slow the progression of some neurodegenerative diseases.
According to researchers, using non-invasive ultrasound technology can be used to treat memory loss associated with Alzheimer's disease.
Study reports neurons carrying a specific genetic variant responded to investigational therapy by reducing the rate of beta amyloid peptide production.
A molecular cascade could help doctors provide early diagnosis of Alzheimer's through a simple blood test, a new study reports.
Researchers report a single dose of an immunotherapy treatment successfully reversed memory loss in a mouse model of Alzheimer's disease.
Experimental cancer drug appears to block damage triggered during the formation of amyloid beta plaques, a new study reports.
Researchers find a failed leukemia drug effectively eliminates the gene CD33 from the surface of immune cells.
Manipulating the rate at which APP is broken down is directly connected to tau levels in the brain, a new study reports.
